{"id":"W4387810362","doi":"10.1016/j.annonc.2023.09.2764","title":"1816P Combination treatment with radium-223 (223Ra) and enzalutamide (enza) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the REASSURE study","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"Bayer; AstraZeneca; Pfizer","keywords":"Medicine; Enzalutamide; Prostate cancer; Radium-223; Docetaxel; Internal medicine; Oncology; Cancer; Androgen receptor; Bone metastasis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000878291,0.0008593726,0.002310994,0.0002548419,0.0002608611,0.0008885543,0.0006515066,0.0007864026,0.002086626],"category_scores_gemma":[0.000670969,0.0004625207,0.001542871,0.000428356,0.0005523702,0.0006603899,0.0003465196,0.002078238,0.0006107364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006703243,"about_ca_system_score_gemma":0.0008217072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00131402,"about_ca_topic_score_gemma":0.003153587,"domain_scores_codex":[0.9996169,0.0001977869,0.00002332339,0.00007181042,0.00003684679,0.00005328361],"domain_scores_gemma":[0.9996653,0.00005721584,0.00007326327,0.00003343481,0.00002040981,0.00015045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8255748,0.009774888,0.02485838,0.0006737009,0.004520619,0.0004704189,0.0002552892,0.002244492,0.02850736,0.0002479114,0.003650676,0.0992215],"study_design_scores_gemma":[0.3447344,0.5208958,0.1066243,0.0001028516,0.005816551,0.001169509,0.0002156673,0.001927496,0.005426195,0.0003253465,0.01267038,0.00009139704],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934834,0.003647313,0.0001659197,0.0004256806,0.0001095903,0.0001978639,0.0006013716,0.00004286725,0.001325914],"genre_scores_gemma":[0.9925649,0.002553925,0.0005317825,0.0004768063,0.0001430526,0.0002078527,0.001515117,0.00002859251,0.001977971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002310994,"threshold_uncertainty_score":0.006980479,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1002521359604472,"score_gpt":0.4213820801680757,"score_spread":0.3211299442076285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}